Skip to main content

Clene Inc.

CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822791

No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Clene Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CLNN: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3948+9
Shares5.52M6.32M+796.5K (+14.4%)
Value$37.8M$26.0M−$11.8M (−31.1%)

New holders (12)

Institutions that held Clene Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CLNN in Q4 2021
InstitutionSharesValue% of portfolio
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.250,235$1.11M0.00%
Marshall Wace, LLP39,039$159.0K0.00%
Parametric Portfolio Associates LLC31,677$130.0K0.00%
Oppenheimer & Co Inc22,214$91.0K0.00%
Occudo Quantitative Strategies LP16,134$66.0K0.01%
Cubist Systematic Strategies, LLC15,076$62.0K0.00%
Group One Trading, L.P.11,683$48.0K0.00%
US Bancorp840$4.00K0.00%
Washington Trust Co1,000$4.00K0.00%
Point72 Hong Kong Ltd854$4.00K0.00%
Simplex Trading, LLC912$3.00K0.00%
Wolverine Asset Management LLC232$00.00%

Sold out (3)

Institutions that held Clene Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of CLNN in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
HRT Financial LP48,840$333.0K
State of Wisconsin Investment Board29,600$202.0K
Citadel Advisors LLC20,594$140.0K